<DOC>
	<DOCNO>NCT00804479</DOCNO>
	<brief_summary>To determine long-term consequence ( 8 year ) initiate patient Parkinson 's disease either pramipexole levodopa . We hypothesize patient initiate therapy pramipexole compare levodopa demonstrate less self-reported disability measure Modified Schwab England ( S/E ) scale 8 year randomization .</brief_summary>
	<brief_title>The Long Term Impact Initiating Pramipexole Versus Levodopa Early Parkinson 's Disease ( CALM-PD Cohort Study )</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Available 301 subject enrol CALMPD study . Those enrolled CALMPD study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>